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The Effect of Dust Mite extract on Esophageal Tight Junctions in
Eosinophilic Esophagitis

Kyle Hinz, M.S.
University of Nebraska, 2018
Advisor: Samantha Simet, PhD
Eosinophilic Esophagitis (EE) is a chronic inflammatory disease that effects individuals of all ages.
EE is mediated by an allergen response, causing the release of thymic stromal lymphopoietin
(TSLP), and subsequent inflammation and eosinophil migration and infiltration of the esophagus
through the activation of the JAK/STAT pathway and CD4+ T-cells. EE has typically been
associated with food allergies, but studies have shown that aeroallergens can cause EE as well.
Current treatments of EE have primarily focused on nonspecific methods, though anti-TSLP is
beginning to be tested as a possible treatment for EE. The aim of this study was to see how
house dust mites affected tight junction function in esophageal cells and determine if
application of anti-TSLP will prevent dust mite’s effects. This was accomplished through a
transwell cell culture model. Dust mites along with experimental conditions Gö 6976, interferongamma, eosinophils, and TSLP synthetic peptide (anti-TSLP) was used to determine how these
conditions affected esophageal cell tight junctions. Transepithelial electrical resistance (TEER)
was recorded to measure epithelial integrity. Cells were analyzed through Prism and imaged by
immunofluorescence staining. Results showed that dust mites caused a decrease in epithelial
resistance through a 24-hour period. Interactions between eosinophils and dust mites caused
further decreases in epithelium resistance. When esophageal cells are treated with anti-TSLP,
the addition of dust mites did not cause a fall in electrical resistance; however, it did not stop
eosinophils disruption of epithelial resistance. Immunofluorescence was used to show changes
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in tight junction function for each condition. These findings indicate that dust mites do affect
esophageal cell function and anti-TSLP negates the disruptive actions of dust mites. Further
studies have to be conducted to understand aeroallergens role in EE and how treatments can be
tailored for aeroallergens.
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Chapter 1: Introduction
What is Eosinophilic Esophagitis
Eosinophilic Esophagitis (EE) is a chronic inflammatory disease of the esophagus
effecting children and adults. EE is an allergy-mediated disease characterized by infiltration of
eosinophils in the esophageal epithelium, which can lead to dysfunction of the esophagus (Fig 1)
(Dellon, 2013). As a result of the increased infiltration of eosinophils into the esophagus, chronic
inflammation occurs, which can lead to a variety of symptoms including dysphagia (food
impaction), development of esophageal rings, linear furrows, white plaques, exudates, high
eosinophil number, and the presence of eosinophil degranulation (Dellon, 2009, Lucendo, 2017).
Prominent symptoms of this disorder change based on the age of the patient. If these symptoms
are left unchecked, they will lead to esophageal remodeling and fibrosis. To be able to diagnosis
EE in a patient, an esophageal biopsy is taken after eight weeks on a proton pump inhibitor
(PPI). This step is used to show that gastric acid is not the cause of the inflammation. Even
though more current studies have recognized PPI-responsive esophageal eosinophilia (PPI-REE),
PPIs are still required in order to formally diagnosis EE. Biopsies that shows greater than 15
eosinophils per high power field (eos/hpf) will signify EE in the patient (Hill, 2014). Currently, the
number of people diagnosed with EE is approximately 1 in 1000 and is the number one diagnosis
for patients that come in for complaints for food dysphagia. That number is currently expected
to increase even with the increased knowledge of EE and better diagnosing techniques (Dellon,
2014).
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Fig. 1: Histology of normal esophagus and EE. A. Normal histology of the esophagus. B. EE biopsy
showing infiltration of eosinophils in the epithelium. C. Shows superficial layering of surface eosinophils
through black arrow. D. An example of an eosinophilic microabscess (Liacouras et al., 2011)

Statistics on Eosinophilic Esophagitis
EE is capable of existing in all ages, with a majority of patients being middle aged adults,
30-50 (Fig 2), and men are being three times more likely to be diagnosed with EE compared to
women. EE is a global disease, but it is far more prevalent in western countries, such as the
United States and European countries due to differences in diet compared to other countries.
(Hruz, 2014). Difficulty in diagnosing EE has made determining what the correlation between
onset of symptoms and diagnosis of EE. According to a 2003 study conducted by Croese et al.,
patients would find strategies to alleviate EE symptoms, such as changing eating habits or
avoiding certain foods that would aggravate EE symptoms. As a result, patients would be able to
undergo long periods of time before diagnosis was determined, resulting in the mean time
between patient reported onset of symptoms and diagnosis to be around 54 months (Croese,
2003). Other studies have shown a similar correlation between onset of symptoms and delayed
diagnoses (Hruz, 2011). By modifying diet and developing strategies to limit food dysphagia and
or EE symptoms, patients can prolong diagnosis of EE, creating a delay in identification of the
disease. These ongoing issues signify the difficultly in diagnosing EE. (Hruz, 2011).
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Fig 2. Age distribution of patients inflicted with EE. Majority of patients that are diagnosed with EE each year are in
the age range of adults, primarily young to middle-aged adults. (Van Rhijin, 2012)

Overall, the prevalence of EE has been increasing since the 1990s, due in part of the
increased research into EE and better diagnostic techniques to differentiate the disease from
other related GI atopic diseases (Fig 3). In the 1980s and 90s, EE was not fully understood and as
a result, was misdiagnosed, often confused with GERD, due to similar symptoms. Both adult and
pediatric cases of EE have been increasing with current US adult prevalence rates of .05 to 1
patients per 1000 inhabitants in the United States, and pediatric prevalence rates of 50.5
patients per 10,000 inhabitants (Dellon, 2018). Which is statistically similar to pediatric
inflammatory bowel disease (Cianferoni, 2015).

Fig. 3. Prevalence trends across multiple cities around the world. Prevalence of EE has increased markedly since the
1990s, through the use of better diagnostic techniques and understanding of EE. (Dellon & Hirano, 2018)
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Fig. 4: Incidence rates of EE in multiple cities around the world. Just like prevalence rates, incidence rates have
increased significantly since the 1990s and is expected to continue to increase. (Dellon & Hirano, 2018)

Incidence rates of EE have also increased (Fig 4). A longitudinal study revealed incidence
rates were 6.37 cases reported per 100,000 inhabitants during the six-year period Disease
incidence was also shown to be 19 times higher in males compared to females (Hruz, 2014).
Gastroesophageal Reflux vs. Eosinophilic Esophagitis
Due to the similar symptoms between gastroesophageal reflux disease (GERD) and EE, it
has been difficult to distinguish between the two diseases. GERD is a gastrointestinal disorder
that can cause mucosal damage in the esophagus, oral cavity, and lungs. This is caused by
abnormal reflux of gastric acid into the esophagus causing damage to the epithelial cells of the
mucosa (Badillo, 2014). Multiple symptoms are similar between the two diseases. Heartburn,
dysphagia (or food impaction), and chest pain are all commonly seen in patients with these
conditions. Biopsies are often needed to determine the difference between the two (MolinaInfante, 2008). Inflammation of the two diseases is induced by different stimuli. Acid reflux into
the lower esophagus is main cause for GERD while EE inflammation is induced by antigenmediated inflammation that corresponds to eosinophil release of type-2 inflammatory
mediators. Treatment of the two diseases are also distinctly different, with GERD being primarily
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treated through the use of proton pump inhibitors (PPI) and EE being treated through topical
corticosteroids and changes in diet. However, EE patients can also receive relief from symptoms
through the use of PPIs, making the overlap between the diseases difficult to differentiate. EE
and GERD are not mutually exclusive diseases. The relationship between the two diseases, along
with the symptoms they both present, show a complex interaction and possible comorbidity
between EE and GERD. However, researchers are still determining whether both diseases can
coexist. Two studies have shown that about 50 percent of patients with EE had acid reflux.
However, the number of patients that have both EE and GERD is still under debate, as there are
inconsistent criteria in defining EE (Cheng, 2014).
New types of diagnostic techniques are always being employed to better differentiate
the two diseases. One such method is measuring the difference in mucosal impedance (MI) by
measuring the degree of spongiosis or epithelial integrity. By measuring MI along various parts
of the esophagus, EE and GERD can be distinguished from each other with great accuracy and
through minimally invasive methods (Choksi, 2017).
Mechanism and signaling pathways involved in Eosinophilic Esophagitis
EE is caused when antigens from allergens bind to receptors in the mucosa of the
esophagus. When the antigen binds the esophageal mucosa, it activates a type 2 (Th2) helper Tcell immune response. Thymic Stromal Lymphopoietin (TSLP) is secreted from the epithelial cell
as a result of antigen binding. TSLP is thought to be the main regulator and cause of the Th2
reaction in EE. TSLP promotes cytokine secretion and also induces maturation of dendritic cells,
which leads to the infiltration of CD4+ T cells and their differentiation into Th2 cells, which
mediate activation of cytokines against allergens. (Cianferoni, 2015). TSLP that is secreted from
the esophageal epithelial cells will bind to TSLP receptor cells on dendritic cells, increasing the
secretion of OX40 ligand. OX40 ligand induces CD4+ T-cells into secreting inflammatory
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cytokines, such as interleukin (IL)-4, IL-5, and IL-13 (Shi, 2017). The binding of TSLP to TSLP
receptors forms a complex that leads to activation of various signal transduction pathway. One
pathway of note is the JAK/STAT pathway (Fig. 5) (Cheng, 2016). The JAK/STAT pathway is
responsible for principal signaling for cytokines and growth factors. Activation of this pathway
will lead to cell proliferation, differentiation, migration, and apoptosis. Inhibition of this signaling
pathway will ultimately lead to decreases of these changes. Unwarranted activation of the
pathway can ultimately lead to inflammation (Rawlings, 2004). TSLP will induce the
phosphorylation of janus kinases (JAK) and lead to the activation of the kinase. The activation of
JAK will lead to the activation of signal transducers and activators of transcription (STAT) factors,
as well as other proteins. JAK phosphorylates a tyrosine residue leading to dimerization of STAT,
subsequent nuclear translocation, and binding to gene promoters for the activation or inhibition
of various target genes (Zhong, 2014). In EE, JAK will specifically phosphorylate STAT 6, which
increases expression of eotaxin and will lead to activation esophageal epithelial cells and
fibroblasts to secrete Eoxtaxin-3. Eoxtaxin-3 is a powerful eosinophil chemoattractant
responsible for the migration of the inflammatory cell to the esophagus (Cheng, 2016). The
cytotoxins secreted from the eosinophils increase the permeability of esophagus, weakening the
tight junctions and dilate intercellular spaces. Due to the inflammation caused by the cytokines,
fibrotic changes occur, causing the symptoms seen within EE patients (Cheng, 2014).
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Fig 5. Pathways activated by TSLP binding. TSLP activates many pathways when binding to its receptor.
Activation of STAT, MAPK, NFKBIA, and others cause an inflammatory response in both airway diseases and EE.
(Zhong et al., 2014)

Tight Junctions
Tight junctions (Fig 6) are important to maintain barrier function between the internal
and external environments. Tight junctions, along with adherens junctions, connect epithelial
cells together, forming a physical barrier and sealing off of the paracellular space (Fig 7)
(Abdulnour-Nakhoul, 2013). In epithelial cells, they connect adjacent cells to one another and
regulate the passage of foreign molecules that come into contact with the cells. Tight are found
at the most apical section between two adjacent cells. Tight junctions are made up of
transmembrane and intracellular proteins, which link up with the actin cytoskeleton. The
function of tight junctions is to seal adjacent cells and regulate paracellular passages of
molecules. Two major proteins that make up tight junctions are occludins and claudins.
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Occludins are transmembrane proteins that regulate passage of macromolecules through the
tight junction. Claudins, another transmembrane protein, are more specific and give tight
junctions size and charge selective properties to regulate macromolecules that enter
paracellularly (Loxham, 2017). Occludins and claudins are anchored intracellularly by cell
junction complexes known as zonula occludens. Zonula occludens are scaffold proteins that
connect junctional protein complexes to the cytoskeleton. (Steelant, 2016). Additional junctional
protein complexes are present, such as adherens junctions and desmosomes are found along
the basolateral cell surface. These junction complexes provide adhesion forces that help
maintain epithelial integrity (Loxham, 2017). In EE, studies have shown that these tight junctions
and adherens junctions are affected; expression of E-cadherin and claudin-1 proteins decreased
while occludins expression increased. Decreases in claudin-1 expression impairs tight junction
barrier function. The significance of increased expression of occludins was not determined
(Abdulnour-Nakhoul, 2013).

Fig. 6: Electron microscopy of junctional complexes. At the apical level, tight junctions can be
seen. Underneath the tight junctions, adherens junctions and desmosomes can be seen as well.
(Fawcett DW, The Cell: An Atlas of Fine Structure, WB Saunders, Philadelphia, 1966, p. 367.)
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Fig. 7: Barrier function proteins in adjacent cells. A. Shows junctional complexes and their
interactions with the cytoskeleton/ basement membrane. B. Shows tight and adheren junctions
mediate cell-cell contact and interact with actin cytoskeleton. (Loxham & Davies, 2017)

Treatments of Eosinophilic Esophagitis
Current treatment of EE typically involves dietary restrictions. The use of elimination
diets has been used with some success. The treatment revolves around systematically removing
certain foods known to cause an allergic response or inflammation. However, despite the
success of these diets, they are difficult to maintain for long periods of time. Studies have found
poor adherence to these diets, with under 50% of patients maintaining the lifestyle change
(Kliewer, 2017). The difficulty in maintaining these diets is likely due to financial and logistical
barriers. These ultimately limit the success of this treatment despite the increased resolution of
symptoms.
Topical corticosteroids are also used to treat inflammatory symptoms of. Steroids
decreased the amount of spongiosis and increased intracellular fluid by strengthening the tight
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junctions in the esophagus. Specifically, filaggrin levels are restored in treated EE patients, as
untreated EE patients have a decrease in the protein. With the increase of filaggrin, spongiosis is
decreased, preventing leakage between the tight junctions (Katzka, 2014). While both diet and
corticosteroid treatments lead to an initial decrease in the symptoms of EE, combination
treatment of both diet and steroids has been shown to significantly decrease relapse of EE
(Reed, 2018).
Despite the success of these treatments, they have been limited in the success of
treating EE completely. The main issue with these treatments are that they are nonspecific.
Targeting specific immune pathways may provide treatment options to help resolve EE
symptoms and treat the disease more effectively. TSLP is one such target. Initial studies
conducted have shown that by neutralizing TSLP, symptoms of EE decreased as well as
resolution of EE histologically (Noti, 2013).
Thymic stromal lymphopoietin
TSLP is an inflammatory interleukin (IL)-7-like cytokine that is secreted from multiple cell
types, such as epithelial cells, epithelial keratinocytes, dendritic cells, and mast cells in response
to antigen binding. TSLP has many connections to many types of allergic disorders, such asthma,
atopic dermatitis, allergic rhinitis, and EE. Two isoforms, long and short, of TSLP have been
described, each with different effects in the body. The two types of TSLP have protective and
deleterious effects based on which one is secreted. Long form TSLP leads to deleterious effects
via barrier dysfunction and inflammatory factors. The short form of TSLP leads to protective
effects of barrier function and is the predominate form of TSLP in healthy individuals. In EE, long
form TSLP is the primary form secreted due to the increase of inflammatory factors caused by
the disorder (Dong, 2016). TSLP is produced by epithelial cells in the esophagus, promoting
migration of immune cells to the area. TSLP binds to TSLP receptors on dendritic cells (DC),
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producing a Th-2 favorable environment (Ito, 2012). TSLP will activate multiple signal
transduction pathways as a result of binding to the TSLP receptor in DCs, such as the JAK/STAT
pathway. As a result of TSLP binding, DCs secrete more OX40 ligand, which regulates DC to T-cell
interaction, and initiate the Th2 cellular response. OX40 ligand will prime CD4+ T cells to secrete
inflammatory cytokines IL-4, 5, and 13, along with tumor necrosis factor alpha (Shi, 2017).
Asthma and TSLP connections
Due to inflammation caused by Th2 cells, EE has pathologic connections with asthma
and related disorders, such as allergic rhinitis and atopic dermatitis. In both diseases, Th-2
inflammation causes structural damage to each of the relevant pathways. In EE, esophageal
epithelium is affected and allows migration of eosinophils to the esophagus. This has parallels to
asthma, in which airway remodeling occurs due to the inflammation caused by a related Th2
reaction. Chronic inflammation in both cases causes structural changes in their associated
organs (Nhu, 2017). Coexistence or comorbidity of EE and Asthma does exist as studies have
found that 23-37.5 percent of patients with EE also have asthma as well (Durrani, 2018). EE
patients are also more likely to have asthma than control patients (Gonzalez-Cervera, 2017).
Treatment options for both of these diseases exist as well. Studies on the use of anti-TSLP has
also been seen to increase resolution of symptoms of both diseases by limiting the amount of
type 2 inflammation caused by the effects TSLP on inflammatory cells. By neutralizing TSLP,
chronic inflammation is inhibited, preventing airway and esophageal remodeling in asthma and
EE respectively (Chen, 2013).
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Fig 8: Type 2 cell immune stimuli, such as dust mite protease activity, leads to an immune response. Activation
of receptors on the epithelium leads to release of innate pro-Th2 cytokines. (Hammad & Lambrecht, 2015)

Dust mites and aeroallergens
Dust mites and other aeroallergens have been found to promote tight junction barrier
dysfunction (Fig 8). Dust mites are an environmental allergen that will produce a Th2 response,
typically causing chronic inflammation. Inflammation caused by exposure to aeroallergens, leads
to structural remodeling and alterations to the epithelial cells as well (Chen, 2013). A study
looking at the effects of dust mites on patients with allergic rhinitis determined that tight
junctions were affected, causing barrier dysfunction. The application of dust mites to the nasal
epithelium resulted in tight junctions becoming more permeable, with increased exposure to
dust mites. Protein and mRNA levels are markedly decreased compared to other tight junction
proteins, specifically occludins and zonula occludens-1. Overall, dust mites have a significant
impact on barrier function in airway pathway diseases (Steelant, 2016). Exposure of dust mites
to the epithelial cells has also been shown to increase the amount of TSLP secreted due to the
damage they cause to the epithelium. Like other types of respiratory diseases associated with
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TSLP, dust mites will lead to overexpression of TSLP, and an increased cascade of inflammatory
factors (Hu, 2017).

Research has recently investigated the role of aeroallergens and EE. A 2003 case study
has shown that a patient with EE had symptoms become more severe during pollen season
compared to winter seasons. The patient had no food allergies and no other significant medical
issues other than asthma. Inflammation become significantly worse during the pollen seasons,
with biopsies during this period showing increased inflammation response and symptoms.
During the winter months, there was less inflammation caused by eosinophils. This case study
hypothesized that aeroallergens have a role in EE. (Fogg, 2003) More recent studies have found
similar results in pediatric patients, with increased esophageal eosinophilia during certain
seasons depending on the season of the aeroallergen (Ram, 2015). A retrospective chart review
of patients with EE also showed a greater number of patients with environmental allergies (58%)
compared to food allergies (28%) (Patel, 2014). Other case studies have shown that aeroallergen
sensitization might also increase with age, as older patients with EE are typically seen with only
aeroallergens and no food allergies compared to pediatric patients (Sugnanam, 2007). These
studies show that aeroallergens might play a greater role in EE than previously thought.
Hypothesis:
Aeroallergens, such as dust mites, impact the development and severity of eosinophilic
esophagitis through thymic stromal lymphopoietin (TSLP) signaling pathway.
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Chapter 2: Materials and Methods
Cell Culture
EPC2 cells, a gift from Hiroshi Nakagawa at the University of Pennsylvania, were
harvested through a 55-year-old male who suffered from Barrett’s esophagus. The cells were
collected from a morphological normal site with testing concluding that they were normal and
had no traces of cancer. Cells were cultured as monolayers in a Corning filtered cap chambered
flask. Esophageal cells were grown in Keratinocyte-SFM medium supplemented with Bovine
Pituitary Extract and human recombinant epidermal growth factor (Invitrogen). Cells were
grown to 80% confluency, at which they were passed to another flask for continued growth or
transferred to a Transwell epithelium plate for experimentation. Cells were passed by adding 5
mL of trypsin-EDTA to the flask to unadhered the cells from the flask surface. After incubations
period of 5 minutes, soybean trypsin inhibitor (STI) (SigmaT9128) was added to deactivate to
trypsin since EPC2 cells are sensitive to trypsin. The contents of the flask are centrifuged for 3
minutes at 1000 rpm at 40C. The cells are resuspended in specific media to needed cell
concentration.
Eosinophils were cultured as well, cells were taken from the cell line AML
14.3D10/CCCKR3 Clone 16 (ATCC CRL-12079). These cells were acquired from the peripheral
blood. Cells were stored in a nitrogen-gas freezer until they were thawed and used. Eosinophils
were grown in RPMI 1640 Gibco (A10-491) media supplemented with .05 mM 2mercaptoethanol, 2 mg/mL G418, 1 mM sodium pyruvate, 2 mM L-Glutamate, and 10% FBS.
Flasks were incubated at 37oC to allow for growth.
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Transwell Cell culture
For experimentation, esophageal cells were placed in Corning™ Transwell Multiple Well
Plate with Permeable Polycarbonate Membrane Inserts. Inserts separate the well into two
compartments to signify a basolateral and luminal compartment. Esophageal cells were placed
inside the inserts (Luminal compartment) with media (200 uL) and 1 mL esophageal media was
placed inside the bottom of each well (basolateral compartment). Plates were placed in a 37oC
incubator to allow esophageal cells to grow to confluence and form monolayer. Cell media was
changed every 2 days to allow for continued growth.
Measuring Epithelial Integrity by Trans Epithelial Electrical Resistance (TEER)
Integrity of the epithelial membrane electrical resistance was measured using the
Millicell ERS-2 Voltohmmeter to measure transepithelial electrical resistance (TEER).
Measurements were acquired at 24 hours after addition of eosinophils and 1, 3, 6, 24, and 48hour time periods. The probe was sanitized with 70 percent ethanol and calibrated using
esophageal media. The probe was then placed in the transwell, with one side of the probe in the
luminal compartment and the other in the basal compartment. Readings were allowed to
stabilize before being recorded. All readings were recorded in Ohms.
Experimental Conditions
Once esophageal cells were confluent on the epithelial plates, experimental conditions
could be applied to each of the wells. The cells in each well were measured by TEER prior to
addition of experimental conditions. Eosinophils (100 eos/ml/ per well) were then added to
basal compartment of specific wells and were allowed 24 hours to equilibrate. Eosinophil
concentration were determined by using the TC20 automatic cell counter (Biorad). Eosinophil
concentration was kept low to limit their effect on the epithelium resistance. Cell TEER was
measured again after the 24-hour period and other experimental conditions were then added to
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each well. All conditions were applied to the basolateral compartments of each well. Conditions
were added individually to each cell or in combination with another experimental condition.
TSLP synthetic peptide (Invitrogen, PEP-049) (20 ng/mL), house dust mites (1 ug/mL), InterferonGamma (ThermoFisher Scientific) (100 ug/mL), and Gö 6976 (Cayman Chemical) (100 ug/mL), a
PKC inhibitor, to strengthen tight junctions, were used in each experiment. Each condition was
repeated at least twice with anti-TSLP, anti-TSLP and eosinophils (anti-TSLP EOS), TSLP and dust
mites (TSLP DM), and TSLP, dust mites and eosinophils (TSLP DM EOS), run in triplet or more.
TSLP synthetic peptide or anti-TSLP, interferon-gamma (IFN-G), and Gö 6976 (G0) was added
after measurement of 24 hours after addition of eosinophils and allowed to incubate three
hours. After the three hours, dust mites were then added to the appropriate wells. Once the
conditions were applied, cells were stored in an incubator at 370C until measurements were
conducted. Plates were allowed to equilibrate for 30 minutes before they were measured. TEER
measurements were taken at 24 hours after added eosinophils, 1, 3, 6, 24, and 48 hours.
Immunofluorescence
Changes in tight junction protein, ZO-1, were observed via immunofluorescence.
Imaging of each experimental condition was taken from eight different plates. Once
experimentation was completed, each well was gently washed 3-5x with PBS. The cells were
then placed in paraformaldehyde for 10 minutes. The wells were then rinsed again with 3-5x
phosphate-buffered saline (PBS) and blocking solution was placed in each for 15 minutes.
Blocking solution was made from 5% bovine serum albumin (Fisher Scientific), sodium azide
(Fisher scientific), triton x-100 (Fisher Scientific), and 1x PBS. Cells were rinsed 3-5 times with
PBS and then placed in the primary antibody Rabbit anti ZO-1 (Thermo Fisher Scientific,
#617300). The cells and antibody were allowed to incubate for 1 hour. The primary antibody
was then rinsed off lightly with PBS and the secondary antibody, Alexa 488 Goat anti-rabbit

17
(Thermo Fisher Scientific) was applied to the cells and allowed to incubate for 1 hour at room
temperature. Once the secondary anti-body incubated, the cells were lightly washed with PBS
and prepped for transfer to a microscope slide. The cells were cut away from the wells with a
scalpel and placed onto the slide. Pro-Long Gold antifade with DAPI (Invitrogen) applied to the
cells and a microscope slide cover sealed the cell sample. The slides were then stored in at 4oC
until they could be analyzed through microscopy.
Microscopy
Esophageal cells were observed through the Zeiss Axio Observer Z1 Research
Microscope. Images were captured with the Axiocam 105 Digital Color camera via the ZEN 2.3
Pro imaging software. After images were captured, Adobe Photoshop was used for post
processing to adjust contrast and brightness of the images to highlight ZO-1.
Statistical Analysis
Statistical analysis was completed using Graphpad Prism 7 software. Data was analyzed
using a one-way ANOVA test to compare significant differences among each of the experimental
conditions. T-tests were also used to compare conditions to the control. The data was
considered significant if p-values were less than 0.05.
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Chapter 3: Results
Determining Dust Mite Concentration
Dust mite concentration was based on initial experimental information prior to the
project starting. Five different dust mite concentrations were used to determine the dosage of
dust mites for the project’s experiments. The concentrations used in this experiment were 1
ul/mL, 10 ug/mL, 25 ug/mL, 50 ug/mL, and 100 ug/mL. Measurements were taken over a 24hour period. The distribution obtained at each concentration of dust mites suggest that dust
mites trigger a response in esophageal cells even at a low dosage. As seen in Fig. 9, over the
course of 24-hour period, addition of dust mites leads to decreased epithelial resistance with
exception at hour 0. Hour 0 increased in resistance due to the added esophageal media added
when dust mites were added to the wells. All concentrations of dust mites show a decrease in
epithelial resistance after 1 hour of application when compared to the control. After the 24
hours, dust mites extract caused a decrease of epithelial resistance by 61 ohms in 1ug/mL, 80
ohms in 10 ug/mL, 58 ohms in 25 ug/mL, 74.33 ohms in 50 ug/mL and 100.5 ohms in 100 ug/mL.
The application of both eosinophils and dust mites lead to a further decrease in resistance (Fig 9
A-E). By comparing the mean differences between DM and DM EOS after 24 hours, DM EOS lead
to a 2 times epithelial resistance decrease when compared to dust mites alone (Fig 9 A-E). This
suggest that dust mites cause an additive effect when applied to eosinophils or they can cause
damage to the epithelium directly, independent of the actions of eosinophils. Though only 50
ug/mL DM and 100 ug/mL DM EOS showed significance by ANOVA, decreases caused by DM and
DM EOS is seen at all concentrations. Due to the response and trends observed from the data,
the 1 ug/mL dust mite concentration was chosen for the experiment. This low dosage was
selected as the minimal threshold response to limit the number of confounding variables.

19

B

A

C

E

D
D

**

**
[Grab
your reader’s
attention
with
Eosinophil
(EOS): 100
eos/mL/well
a great quote from the document
should
significance
or**=
useANOVA
this space
to emphasize
a for
50
ug
DM
and
100ug
DM.
key point. To place this text box
anywhere on the page, just drag
* = significant vs control p-value <.05
it.]
*

Fig 9. Changes in epithelial resistance based on various concentrations of dust mites (A-D). Dust mites decreased
epithelial resistance at each concentration level used. The combination of dust mites and eosinophils lead to even
greater decreases in epithelial integrity.
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Effect of Dust Mites and Eosinophils on Epithelial Resistance
Based on the trends of decreased epithelial resistance seen in prior experiments by dust
mites and eosinophils, we sought to see if application of anti-TSLP would counteract the effects
of dust mites and eosinophils. Throughout the experiment, there were changes seen based on
the conditions applied to the esophageal cells. During the first and third hours of the experiment
on each plate, there were no changes seen in any of the experimental conditions compared to
the control. Alterations in TEER begin to occur at six-hours. Compared to the control, there was
a significant decrease in epithelial resistance in the anti-TSLP DM EOS treated cells (Fig. 10C,
p<.05). The difference in mean between this condition and the control was approximately 15
ohms. At the 24-hour condition, anti-TSLP EOS along with anti-TSLP DM EOS were seen to
significantly decrease epithelial resistance compared to the control (Figure 10D, p<.05). TSLP
EOS mean decrease compared to the control was 44.3 ohms. Anti-TSLP DM EOS had a mean
decrease of 55.72 ohms compared to the control. At the 48-hour measurement, three different
condition saw significant changes compared to the control. Anti-TSLP EOS and anti-TSLP DM EOS
saw significant decreases in epithelial resistance, while G0 saw a significant increase in
resistance, which was expected (Fig 10E, p<.05). anti-TSLP EOS decreased by a mean of 28.65
ohms and anti-TSLP DM EOS decreased by a mean of 48.16 ohms. Gö 6976, was the only
condition to increase epithelial resistance, increased by a mean of 38.5 compared to the control.
Gö 6976 was also used as an additional control as well, by strengthening tight junction function.
The Gö 6976 control was used to ensure esophageal cells were normal and were not mutated
through multiple passages of cells during cell culture. Gö 6976 works by being a PKC inhibitor,
preventing activation of the JAK STAT pathway. While not significant, the graphs show an
additional decrease in resistance when added to the anti-TSLP EOS condition compared to anti-
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TSLP EOS alone. Application of dust mites also lead to a decrease in epithelial resistance as well
as seen in Fig. 9.
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Fig 10. Changes in epithelial resistance based on different experimental conditions applied to each well (AE). Over the course of the 48 hours, decreased epithelial resistance was seen in wells containing EOS, antiTSLP EOS, and anti-TSLP DM EOS
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ZO-1 function impaired by eosinophils and dust mites
After seeing the decreased epithelium values for wells containing dust mites and
eosinophils, tight junctions were imaged to determine dust mites and eosinophils effects on
these proteins. Figure 11 shows differences between the control, Eosinophils, anti-TSLP, and
interferon-gamma. The control shows intact tight junctions with ZO-1 forming a clear line
between two adjacent cells. The nuclei of the cells are shown through the use of DAPI. TSLP
shows a similar look to the control in Figure 11B. anti-TSLP slides had TSLP synthetic peptide
added to the well. Tight junctions remained intact as well. Figure 11C shows wells applied with
eosinophils. Tight junctions were decreased due to the cytotoxins released from eosinophils. As
a result, immunofluorescence of ZO-1 was diminished compared to the control. Figure 12 shows
the other four conditions used in the experiment. G0 was a control that would strengthen tight
junctions. As the image shows, ZO-1 is very prominently displayed in the microscope slide with
the proteins appearing between two esophageal cells. This was expected due to the increase in
tight junction function that G0 adds. Imaging of TSLP DM shows multiple ZO-1 protein staining.
Anti-TSLP limited the affect dust mites cause on tight junction proteins. This phenomenon was
also seen in the epithelial resistance as well. In figure 12G, anti-TSLP EOS lead to a decrease in
the amount of ZO-1 between esophageal cells. As seen in the image, very few ZO-1 proteins
showed up and epithelial resistance confirms the decrease in tight junction proteins as seen in
Fig. 10. Lastly, anti-TSLP DM EOS showed the most major changes in tight junction proteins.
Large segments of the image show many ZO-1 proteins throughout the imaged area. Many of
these proteins are close to the nuclei of esophageal cells as shown by DAPI. There is also no
discernable pattern to ZO-1 proteins around the nuclei and not clear barrier is seen between
esophageal cells. Each of these images indicate the changes to tight junction proteins under
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different experimental conditions. Most of the changes seen are conditions that lead to a
decrease in epithelial cell resistance, causing leaky tight junction barriers.
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Fig. 11 Immunofluorescence imaging of ZO-1. A) Control shows a ZO-1 present between two different cells B) TSLP
showed ZO-1 similar to the control, with defined ZO-1 between cells C) Eosinophil: Decreased number of ZO-1 is
signified with decreased TEER readings D) Interferon-Gamma: Had limited effect on TEER readings and ZO-1 is still
present between esophageal cells. Tight junction protein ZO-1 in green and esophageal cell nuclei shown in blue.
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Fig. 12 Immunofluorescence imaging of ZO-1. E) Gö 6976 show tight junctions separating two esophageal cells F)
anti-TSLP EOS show dispersed tight junction proteins, leading to decreased epithelial resistance G) anti-TSLP DM
shows retained epithelial resistance, however, imaging of anti-TSLP DM showed limited number of ZO-1 H) antiTSLP DM EOS: Very dispersed ZO-1 with increased staining by the nucleus of the cells, showing increased
intracellular ZO-1. Tight junction protein ZO-1 in green and esophageal cell nuclei shown in blue.
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Chapter 4: Discussion
In Eosinophilic Esophagitis, chronic inflammation leads to esophageal restructuring,
causing eosinophil infiltration and tight junction disorder. Through experiments conducted prior
and during the project, addition of dust mite extract to esophageal cells lead to a decrease in
epithelial resistance. Every concentration level of dust mite extract lead to a decrease in
resistance starting at 1 hour. The concentration of dust mites chosen was based on the trends
seen in the lowest concentration and to determine the lowest dosage of dust mites that causes
a response in esophageal cells. Dust mites can cause tight junction dysfunction by two different
process, protease or receptor-based activity. These two pathways can lead to a decrease in
epithelial resistance. Dust mite’s interaction with eosinophils also increases the magnitude of
dysfunction as well, with greater decreases in resistance.
Based on the experiment results, dust mite activity is inhibited with the addition of an
anti-TSLP compound. Figure 9 shows the TSLP DM condition throughout the 48-hour period.
With the application of anti-TSLP, dust mites did not exhibit a negative effect on epithelial
resistance. This might suggest that dust mites activate esophageal cells through a receptor
mediated response cause to secrete TSLP instead of causing protease activity (Hammad, 2015).
Adding anti-TSLP to dust mites will inhibit the effect of TSLP on esophageal cells a counteract the
response caused by dust mites. This is largely seen when comparing the dust mite only response
in esophageal cells. When dust mites are the only condition added to the esophageal cells,
epithelial resistance decreased with prolonged exposure to dust mites. When cells were
pretreated with anti-TSLP and dust mites were applied to the cells, the epithelial resistance of
the cells were not significantly different from the control. This might suggest that protease
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activity of dust mites is not effective in esophageal cells and only receptor mediated pathways
are activated when dust mites are applied to the cells.
There is also an interesting interaction between dust mites and eosinophils that
enhances the disruption of tight junctions in the esophagus. When eosinophils were added to
the wells with esophageal cells, tight junction dysfunction occurred, leading to a decrease in the
epithelial resistance. This response is expected due to inflammatory factors and cytotoxins that
are released from eosinophils leads to barrier disruption and the cells become leakier. When
anti-TSLP is added to this is added to eosinophils, there is no effect on eosinophil function and
epithelial resistance remains decreased by the same level as eosinophils alone. This suggests
that anti-TSLP does not limit stop eosinophils from degranulation and releasing factors that lead
to tight junction disruption. However, other studies have suggested the opposite, with
decreased eosinophil effect with the application of anti-TSLP antibodies (Gauvreau, 2014). TSLP
is the main regulator of EE and will lead to infiltration of eosinophils to esophagus. However,
TSLP does not have an effect on eosinophils once they have already infiltrated the epithelium,
so anti-TSLP will not stop disruption from occurring from eosinophils. Lastly, when dust mites
are added to the wells containing anti-TSLP and eosinophils, it leads to a greater decrease in
epithelial resistance. It suggests that dust mites and eosinophils interact with each other to lead
to further disruption compared when these two are separate. Dust mites or other similar
aeroallergens might cause eosinophils to increase the secretions of cytotoxins and lead to
greater degranulation of eosinophils. As a result, tight junctions were further affected as seen in
imaging. A 2007 study shows that dust mites cause activation of eosinophils by binding to the
formyl peptide receptor (FPR) and formyl peptide receptor-like 1 (FPRL1). When dust mites bind
to these receptors, they cause activation of eosinophils and cause degranulation (Svensson,
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2007). This process might explain why the combination of eosinophils and dust mites leads to
greater decreases in epithelial resistance and disruption of tight junctions.
Limitations and issues did arise during the experiment that should be noted. Growth on
the epithelial plates was difficult throughout the project. After the cells were placed on the
transwell plates, difficulties growing a monolayer on the inserts were encountered. As the data
shows, there were decreased epithelial resistance readings in each of the wells, with an average
of 200 Ohms or lower. A lower passage cells of the same cell line was used to try to combat the
issue, however, it was unsuccessful in raising the epithelial resistance of the esophageal cells.
Lower passage cells are at less risk to undergo mutation or differentiation. Cells that undergo
high number of passages can change the cell characteristics over time. Using lower passage cells
ensured that cells were not affected by alterations in cell function, decreasing TEER (BriskeAnderson, 1997). Different bottles of esophageal media were also used to determine if there
were any contamination issues occurring that were inhibiting the growth of the cells. Cells were
also allowed to grow as long as needed to ensure the monolayer formed on the transwell
inserts. However, despite these strategies to increase epithelial resistance in esophageal cells,
resistance remained low. As a result, trends and significance of the data might be impacted the
diminished cell resistance, as well as imaging of tight junction proteins. This was especially seen
during the imaging of ZO-1. With less esophageal cells forming a monolayer, less tight junction
proteins were seen when cells were imaged. This made it difficult to determine changes in tight
junction presence as most of the barriers between cells were already leaky, caused by the
decrease in cells.
Dosage of anti-TSLP might have had an effect on experimental results as well. A dosage
was based on a previous study for allergic asthma. Studies using anti-TSLP in airway related
diseases, have shown a decrease in tight junction dysfunction with the addition of anti-TSLP.
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Based on the results, anti-TSLP was effective in preserving epithelial resistance at the
concentration of 20 ug/mL. Despite the success of anti-TSLP stopping the action of dust mites,
more experiments need to be conducted to learn the effective concentrations of anti-TSLP to
dust mites. This would give a better idea on how anti-TSLP affects dust mite function and
provide the amount needed to maintain epithelial resistance.
Issues with staining for immunofluorescence also occurred. Staining was not optimal for
showing tight junction dysfunction. Problems in immunofluorescence could have come from
multiple areas. Two issues that present themselves as the most logical areas is in growth of the
cells and washing the cells during the staining protocol. As mentioned previously, there were
issues involved in raising the epithelial resistance on the transwell cell culture plates. Since the
cells were leaky at the start, the number of tight junction proteins might have been reduced
from the start. This would lead to decreased number of ZO-1 in the stain making it difficult to
demonstrate how tight junctions were affected. Another possible area is the washing of cells
during the staining process. The antibody staining for immunofluorescence protocol calls for
multiple washes throughout the process to remove excess antibody and prepare it for the next
step. During this process, cells might have washed away during removal of the PBS wash. This
would lead to less cells available and less ZO-1 for the primary antibody to bind to. Both of these
possibilities led to poor imaging of ZO-1.
Future studies should continue into looking at the association between aeroallergens
and EE. As of today, environmental allergies remain more controversial as a cause for EE than
food allergies. More research as to look at the various environmental allergies and identify
mechanisms lead to EE. Other treatment options could also focus on using JAK inhibitors as well.
Since TSLP activates the JAK/STAT pathway, focusing on this pathway could lead to a decrease in
inflammation factors and chemotaxis of eosinophils. Current JAK inhibitors are currently used to
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address inflammatory diseases such as rheumatoid arthritis, psoriasis, and inflammatory bowel
disease (Schwartz, 2017). Since eosinophilic esophagitis is known to activate this pathway to
lead to eosinophil attraction and inflammation in the esophagus, JAK inhibitors could become a
possible treatment option for patients. Looking at the mechanisms and treatments of EE will
lead to further understanding of how EE works and ways to fully combat the issues that EE
presents.
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